| Abstrakt: |
A recent study conducted at Rockefeller University in New York City focused on small molecule inhibitors of clot retraction, a crucial process in clot stabilization. By utilizing a high-throughput screening method, researchers identified several compounds from drug-repurposing libraries that showed promise as inhibitors of clot retraction. These findings may lead to the development of novel mechanisms for inhibiting thrombosis, offering potential new avenues for therapeutic interventions in the future. [Extracted from the article] |
